El 2 de mayo de 2018 publicamos una tabla con las acciones de los virus en la elaboración de los ATMP´s. La EMA los clasifica como: gene therapy medicines: these contain genes that lead to a therapeutic, prophylactic or diagnostic effect. They work by inserting 'recombinant' genes into the body, usually to treat a variety of diseases, including genetic disorders, cancer or long-term diseases. A recombinant gene is a stretch of DNA that is created in the laboratory, bringing together DNA from different sources; somatic-cell therapy medicines: these contain cells or tissues that have been manipulated to change their biological characteristics or cells or tissues not intended to be used for the same essential functions in the body. They can be used to cure, diagnose or prevent diseases; tissue-engineered medicines: these contain cells or tissues that have been modified so they can be used to repair, regenerate or replace human tissue; Dán...
Blog de Medicamentos de terapias avanzadas (MTA): de medicamentos de terapias génicas y de medicamentos de terapias celulares somáticas autorizadas por la EMA y la FDA, principalmente.